Seminars in Hematology
Volume 41, Issue 1 , Pages 34-40, January 2004

Genetic defects leading to hereditary thrombotic thrombocytopenic purpura

  • Koichi Kokame

      Affiliations

    • National Cardiovascular Center Research Institute, Osaka, Japan
  • ,
  • Toshiyuki Miyata

      Affiliations

    • Corresponding Author InformationAddress correspondence to Toshiyuki Miyata, PhD, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    • National Cardiovascular Center Research Institute, Osaka, Japan

Abstract 

In patients with thrombotic thrombocytopenic purpura (TTP), unusually large multimers of von Willebrand factor (VWF) circulate in the plasma. This is caused by a functional deficiency of VWF-cleaving protease, ADAMTS-13. Although TTP usually occurs as an acquired form due to autoantibodies against ADAMTS-13, the condition may be inherited in an autosomal recessive fashion. Thus far, genomic DNA from 23 patients with hereditary TTP and their families has been analyzed and 33 causative mutations identified in the ADAMTS13 gene: 19 missense, five nonsense, five frameshift, and four splice mutations. Common missense polymorphisms have been also found, one of which significantly reduces ADAMTS-13 activity. No cases have been found without mutations in the ADAMTS13 gene, suggesting that genetic defects in ADAMTS13 are the dominant cause of hereditary TTP. Further analysis may reveal the genetic background associated with acquired TTP and other thrombotic diseases.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants-in-aid from the Ministry of Health, Labour, and Welfare of Japan, and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

PII: S0037-1963(03)00267-1

doi:10.1053/j.seminhematol.2003.10.002

Seminars in Hematology
Volume 41, Issue 1 , Pages 34-40, January 2004